Completed in July, the blinded screening trial investigated data from 24 breast radiologists who looked at 177 total cases (32 normal, 147 ground-truth lesions). Researchers led by Yulei Jiang, PhD, from the University of Chicago found that QTscan had high sensitivity and specificity, as well as a -0.05 area under the curve margin.

The QTscan system. Image courtesy of QT Imaging.

Exact data were not disclosed by the company.